RVMD

NASDAQ 已收盘

Revolution Medicines

159.43 USD
▼-0.39-0.24%
盘后 159.98 +0.34%
2026-11-19
市值
$35.42B
市盈率
—
EPS
-9.14
股息率
—
52 周区间
69.50 – 224.31
成交量
3.35M
Beta
1.43
目标价
274.68
52W 低 69.5052W 高 224.31
价格走势

公司简介

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company’s research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236)...

关联新闻